New agents for hyperkalemia

Comment

Christina M Yuan et al. N Engl J Med. 2015.

. 2015 Apr 16;372(16):1570.

doi: 10.1056/NEJMc1501933.

No abstract available

Comment in

New agents for hyperkalemia.
Weir MR, Bakris GL, Pitt B. Weir MR, et al. N Engl J Med. 2015 Apr 16;372(16):1570-1. doi: 10.1056/NEJMc1501933. N Engl J Med. 2015. PMID: 25875263 No abstract available.
New agents for hyperkalemia.
Packham DK, Rasmussen HS, Singh B. Packham DK, et al. N Engl J Med. 2015 Apr 16;372(16):1571-2. doi: 10.1056/NEJMc1501933. N Engl J Med. 2015. PMID: 25884064 No abstract available.

Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.
Weir MR, Bakris GL, Bushinsky DA, Mayo MR, Garza D, Stasiv Y, Wittes J, Christ-Schmidt H, Berman L, Pitt B; OPAL-HK Investigators. Weir MR, et al. N Engl J Med. 2015 Jan 15;372(3):211-21. doi: 10.1056/NEJMoa1410853. Epub 2014 Nov 21. N Engl J Med. 2015. PMID: 25415805 Clinical Trial.
Sodium zirconium cyclosilicate in hyperkalemia.
Packham DK, Rasmussen HS, Lavin PT, El-Shahawy MA, Roger SD, Block G, Qunibi W, Pergola P, Singh B. Packham DK, et al. N Engl J Med. 2015 Jan 15;372(3):222-31. doi: 10.1056/NEJMoa1411487. Epub 2014 Nov 21. N Engl J Med. 2015. PMID: 25415807 Clinical Trial.